Skip to main content
Have a personal or library account? Click to login
PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis Cover

PET/CT imaging in polymyalgia rheumatica: praepubic 18F-FDG uptake correlates with pectineus and adductor longus muscles enthesitis and with tenosynovitis

Open Access
|Jan 2017

References

  1. Nesjet G, Nesjet R. Giant cell arteritis and polymyalgia rheumatica. In: Ball GV, Bridges SL Jr., editors. Vasculitis (2nd ed.), Oxford University Press; 2008. p.307-16.
  2. Pipitone N, Salvarani C. Update on polymyalgia rheumatica. Eur J Intern Med 2013; 24: 583–9. 10.1016/j.ejim.2013.03.003
  3. Salvarani C, Cantini F, Olivieri I, Barozzi L, Machioni L, Niccoli L, et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997; 127: 27-31. 10.7326/0003-4819-127-1-199707010-00005
  4. Cantini F, Nicoli L, Nannini C, Padula A, Olivieri I, Boiardi L, et al. Inflammatory changes of the hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 2005; 23: 462-8.
  5. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672-80. 10.7326/0003-4819-97-5-672
  6. Hamrin B. Polymyalgia arteritica. Acta Med Scand 1972; 533: 1-131.
  7. Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434-9. 10.1136/ard.38.5.434
  8. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981; 40: 1-5. 10.1136/ard.40.1.1
  9. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984; 13: 322-8. 10.1016/0049-0172(84)90012-X
  10. Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012; 71: 484-92. 10.1136/annrheumdis-2011-200329
  11. Glaudemans AWJM, Signore A. FDG-PET/CT in infections: the imaging method of choice? Eur J Nucl Med Mol Imaging 2010; 37: 1986-91. 10.1007/s00259-010-1587-x
  12. Jaruskova M, Belohlavek O. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur J Nucl Med Mol Imaging 2006; 33: 913–8. 10.1007/s00259-006-0064-z
  13. Kubota K, Nakamoto Y, Tamaki N, Kanegae K, Fukuda H, Kaneda T, et al. FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med 2011; 25: 355-64. 10.1007/s12149-011-0470-6
  14. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation-current and emerging clinical applications. Clin radiol 2015; 70: 787-800. 10.1016/j.crad.2015.03.010
  15. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology 2007; 46: 672-7. 10.1093/rheumatology/kel376.
  16. Yamashita H, Inoue M, Takahashi Y, Kano T, Mimori A. The natural history of asymptomatic positron emission tomography: positive giant cell arteritis after a case of self-limiting polymyalgia rheumatica. Mod Rheumatol 2012; 22: 942-6. 10.1007/s10165-012-0689-7
  17. Rehak Z, Vasina J, Nemec P, Fojtik Z, Koukalova R, Bortlicek Z, et al. Various forms of 18F-FDG PET and PET/CT findings in patients with polymyalgia rheumatica. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2015; 159: 629-36. 10.5507/bp.2015.026
  18. Yamashita H, Kubota K, Takahashi Y, Minaminoto R, Morooka M, Ito K, et al. Whole-body fluorodeoxyglucose positron emission tomography/computed tomography in patiens with active polymyalgia rheumatica: evidence for distinctive bursitis and large-vessel vasculitis. Mod Rheumatol 2012; 22: 705-11. 10.1007/s10165-011-0581-x
  19. Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study in 35 patients. Arthritis Rheum 2006; 55: 131-7. 10.1002/art.21699
  20. Lensen KDF, Comans EFI, Voskuyl AE, Van der Laken CJ, Brouwer E, Zwijnenburg AT, et al. Large-Vessel Vasculitis: Interobserver Agreement and Diagnostic Accuracy of 18 F-FDG-PET/CT. Biomed Res Int 2015; 2015: 914692. 10.1155/2015/914692
  21. Fuchs M, Briel M, Daikeler T, Walker UA, Rasch H, Berg S, et al. The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. Eur J Nucl Med Mol Imaging 2012; 39: 344-53. 10.1007/ s00259-011-1967-x
  22. Taniguchi Y, Nakayama S, Terada Y. Clinical implication of FDG-PET/CT in monitoring disease activity in large-vessel giant cell arteritis linked with secondary polymyalgia rheumatica. Case Reports in Internal Medicine 2014; 1: 6-9. 10.5430/crim.v1n1p6
  23. Glaudemans AWJM, de Vries EFJ, Galli F, Dierckx RAJO, Slart RHJA, Signore A. The use of 18F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases. Clinical and Developmental Immunology 2013; 2013: 623036. 10.1155/2013/623036
  24. Wakura D, Kotani T, Takeuchi T, Komori T, Yoshida, 1 Makino S, et al. Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR? PLoS One 2016 ; 11: e0158509. 10.1371/journal. pone.0158509
  25. Toriihara A, Seto Y, Yoshida K, Umehara I, Nakagawa T, Tassei MD, et al. F-18 FDG PET/CT of Polymyalgia Rheumatica. Clin Nucl Med 2009; 34: 305-6. 10.1097/RLU.0b013e31819e51fd
  26. Kotani T, Komori T, Kanzaki Y, Takeuchi T, Wakura D, Iimori A, et al. FDG-PET/CT of polymyalgia rheumatica. Mod Rheumatol 2011; 21: 334-6. 10.1007/s10165-010-0382-7
  27. Park JS, Pyo JY, Park HJ, Lee HS, Kang Y, Kang MI, et al. Typical 18-FDG-PET/CT Findings of Polymyalgia Rheumatica: A Case Report. Journal of Rheumatic Diseases 2013; 20: 113-7. 10.4078/jrd.2013.20.2.113
  28. Sondag M, Guillot X, Verhoeven F, Blagosklonov O, Prati C, Boulahdour H et al. Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study. Rheumatology 2016; 55:1452-7. 10.1093/rheumatology/kew202
  29. Mackie SL, Pease CT, Fukuba E, Harris E, Emery P, Hodgson R, et al. Wholebody MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Ann Rheum Dis 2015; 74: 2188-92. 10.1136/annrheumdis-2015-207395
  30. Mackie SL, Mc Gonagle DG. Response to:’A relationship between extracapsular involvement and response to steroid treatment in polymyalgia rheumatica: too soon to conclude?’by Yang et al. Ann Rheum Dis 2016; 75: e17. 10.1136/annrheumdis-2015-208962
  31. Ruta S, Rosa J, Navarta DA, Saucedo C, Catoggio LJ, Monaco RG, et al. Ultrasound assessment of new onset bilateral painful shoulder in patiens with polymyalgia rheumatica and rheumatoid arthritis. Clin Rheumatol 2012; 31: 1383–7. 10.1007/s10067-012-2016-2
  32. Cimmino MA, Parodi M, Zampogna G, Barbieri F, Garlaschi G. Polymyalgia rheumatica is associated with extensor tendon tenosynovitis but not with synovitis of the hands: a magnetic resonance imaging study. Rheumatology 2011; 50: 494–9. 10.1093/rheumatology/keq367
DOI: https://doi.org/10.1515/raon-2017-0001 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 8 - 14
Submitted on: Aug 29, 2016
Accepted on: Dec 14, 2016
Published on: Jan 14, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Zdenek Rehak, Andrea Sprlakova-Pukova, Zbynek Bortlicek, Zdenek Fojtik, Tomas Kazda, Marek Joukal, Renata Koukalova, Jiri Vasina, Jana Eremiasova, Petr Nemec, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.